Attached files
| file | filename |
|---|---|
| EX-3.2 - EX-3.2 - Genprex, Inc. | ex3-2.htm |
| EX-3.1 - EX-3.1 - Genprex, Inc. | ex3-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
April 3, 2018
Date of report (Date of earliest event reported)
GENPREX, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-38244
|
90 - 0772347
|
|
(State or other jurisdiction of
incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer
Identification Number)
|
|
|
|
|
|
100 Congress Avenue, Suite 2000, Austin, TX
|
|
78701
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code: (512) 370-4081
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On April 3, 2018, in connection with the April 3, 2018 closing of the initial public offering (the “Initial Public Offering”) of the common stock of Genprex, Inc. (the “Company”), the Company filed an amended and restated certificate of incorporation (the “Amended and Restated Certificate”) with the Secretary of State of the State of Delaware. Then Company’s board of directors and stockholders had previously approved the Amended and Restated Certificate effective as of and contingent upon the closing of the Initial Public Offering.
A copy of the Amended and Restated Certificate is furnished herewith as Exhibit 3.1 and is incorporated herein by reference.
Amendment and Restatement of Bylaws
Effective as of April 3, 2018, in connection with the Initial Public Offering, the Company adopted amended and restated bylaws (the “Amended and Restated Bylaws”). Then Company’s board of directors and stockholders had previously approved the Amended and Restated Bylaws effective as of and contingent upon the closing of the Initial Public Offering.
A copy of the Amended and Restated Bylaws is furnished herewith as Exhibit 3.2 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit
Number
|
|
Description
|
|
3.1
|
|
|
|
3.2
|
||
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
GENPREX, INC.
|
|
|
|
|
|
|
|
|
Date: April 10, 2018
|
By:
|
/s/ Ryan Confer
|
|
|
|
|
Ryan Confer
|
|
|
|
|
Chief Financial Officer
(Principal Financial Officer)
|
|
INDEX TO EXHIBITS
|
Exhibit
Number
|
|
Description of Exhibit
|
|
|
|
|
|
3.1
|
|
|
|
3.2
|
||